PL3166680T3 - Profilaktyka przedekspozycyjna anty-hsv - Google Patents
Profilaktyka przedekspozycyjna anty-hsvInfo
- Publication number
- PL3166680T3 PL3166680T3 PL15818554.6T PL15818554T PL3166680T3 PL 3166680 T3 PL3166680 T3 PL 3166680T3 PL 15818554 T PL15818554 T PL 15818554T PL 3166680 T3 PL3166680 T3 PL 3166680T3
- Authority
- PL
- Poland
- Prior art keywords
- exposure prophylaxis
- hsv
- hsv pre
- prophylaxis
- exposure
- Prior art date
Links
- 230000003622 anti-hsv Effects 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462021589P | 2014-07-07 | 2014-07-07 | |
| PCT/US2015/039421 WO2016007538A1 (en) | 2014-07-07 | 2015-07-07 | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3166680T3 true PL3166680T3 (pl) | 2024-03-25 |
Family
ID=55016233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15818554.6T PL3166680T3 (pl) | 2014-07-07 | 2015-07-07 | Profilaktyka przedekspozycyjna anty-hsv |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10052329B2 (pl) |
| EP (2) | EP3166680B1 (pl) |
| JP (3) | JP2017527610A (pl) |
| KR (1) | KR20170063512A (pl) |
| CN (2) | CN114469958A (pl) |
| AU (3) | AU2015287994B2 (pl) |
| BR (1) | BR112017000285A2 (pl) |
| CA (1) | CA2954526C (pl) |
| ES (1) | ES2964529T3 (pl) |
| IL (2) | IL249938B (pl) |
| MX (1) | MX2017000059A (pl) |
| PL (1) | PL3166680T3 (pl) |
| SG (2) | SG11201700061PA (pl) |
| WO (1) | WO2016007538A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11071745B2 (en) * | 2014-07-07 | 2021-07-27 | Elian Llc | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits |
| KR20170063512A (ko) | 2014-07-07 | 2017-06-08 | 프로필락시스 엘엘씨 | 바이러스 예방 치료 방법 및 사전-노출 예방 키트 |
| CN110325187B (zh) * | 2017-02-08 | 2022-09-30 | 生物环境有限公司 | N-氨基甲酰亚胺基-5-(1-甲基-1h-吡唑-4-基)-2-萘甲酰胺在制备治疗流感的药物中的用途 |
| NZ760339A (en) * | 2017-06-28 | 2023-06-30 | Aicuris Gmbh & Co Kg | Intravaginally applicable devices comprising antiviral compounds |
| US20210379089A1 (en) * | 2018-10-23 | 2021-12-09 | Eastern Virginia Medical School | Pharmaceutical compositions and methods of making on demand solid dosage formulations |
| WO2020092990A1 (en) * | 2018-11-02 | 2020-05-07 | Eastern Virginia Medical School | Pharmaceutical compositions and methods of making a patch formulation for transdermal delivery |
| JP2022521651A (ja) | 2019-02-25 | 2022-04-11 | エリアン リミテッド ライアビリティ カンパニー | バラシクロビルおよびファムシクロビルの組合せによる単純ヘルペスの治療 |
| US20210322469A1 (en) * | 2020-04-20 | 2021-10-21 | Regents Of The University Of Minnesota | Zinc and copper for the prophylaxis and treatment of covid-19 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795721A (en) | 1990-06-11 | 1998-08-18 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands of ICP4 |
| CN100396344C (zh) | 1998-04-21 | 2008-06-25 | 瑞克尔科感染公司 | 用于将液体至半固体的制剂给药至患者粘膜腔内的施用器 |
| GB9819898D0 (en) | 1998-09-11 | 1998-11-04 | Smithkline Beecham Plc | New vaccine and method of use |
| DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
| US20020091097A1 (en) | 2000-09-07 | 2002-07-11 | Bratzler Robert L. | Nucleic acids for the prevention and treatment of sexually transmitted diseases |
| CN101405010B (zh) * | 2006-03-22 | 2013-03-06 | 星药股份有限公司 | 避孕组合物 |
| EP2274311A2 (en) * | 2008-03-28 | 2011-01-19 | Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Compounds and methods for the treatment of viral infection |
| US8853223B2 (en) * | 2010-09-17 | 2014-10-07 | G2L Touch, Inc. | Therapeutic composition to treat lesions caused by herpes simplex virus |
| WO2011156416A1 (en) * | 2010-06-11 | 2011-12-15 | Gilead Sciences, Inc. | Topical antiviral formulations for prevention of transmission of hsv-2 |
| WO2012158779A1 (en) * | 2011-05-17 | 2012-11-22 | Reprotect, Inc. | Reusable intravaginal delivery device, system, and method |
| JP6170044B2 (ja) * | 2011-07-20 | 2017-07-26 | エフ． カイザー，パトリック | 薬物送達のための膣内デバイス |
| NZ701881A (en) | 2012-05-16 | 2016-10-28 | Immune Design Corp | Vaccines for hsv-2 |
| KR20170063512A (ko) | 2014-07-07 | 2017-06-08 | 프로필락시스 엘엘씨 | 바이러스 예방 치료 방법 및 사전-노출 예방 키트 |
-
2015
- 2015-07-07 KR KR1020177003101A patent/KR20170063512A/ko not_active IP Right Cessation
- 2015-07-07 AU AU2015287994A patent/AU2015287994B2/en active Active
- 2015-07-07 MX MX2017000059A patent/MX2017000059A/es unknown
- 2015-07-07 BR BR112017000285A patent/BR112017000285A2/pt not_active Application Discontinuation
- 2015-07-07 WO PCT/US2015/039421 patent/WO2016007538A1/en active Application Filing
- 2015-07-07 ES ES15818554T patent/ES2964529T3/es active Active
- 2015-07-07 PL PL15818554.6T patent/PL3166680T3/pl unknown
- 2015-07-07 SG SG11201700061PA patent/SG11201700061PA/en unknown
- 2015-07-07 EP EP15818554.6A patent/EP3166680B1/en active Active
- 2015-07-07 US US14/793,550 patent/US10052329B2/en active Active
- 2015-07-07 JP JP2017522446A patent/JP2017527610A/ja active Pending
- 2015-07-07 CA CA2954526A patent/CA2954526C/en active Active
- 2015-07-07 CN CN202111625589.0A patent/CN114469958A/zh active Pending
- 2015-07-07 CN CN201580048049.7A patent/CN106794336B/zh active Active
- 2015-07-07 EP EP23209083.7A patent/EP4342545A2/en active Pending
- 2015-07-07 SG SG10201913641XA patent/SG10201913641XA/en unknown
-
2017
- 2017-01-05 IL IL249938A patent/IL249938B/en active IP Right Grant
-
2020
- 2020-04-12 IL IL273932A patent/IL273932B2/en unknown
- 2020-06-12 AU AU2020203896A patent/AU2020203896B2/en active Active
-
2021
- 2021-05-21 JP JP2021086021A patent/JP2021138723A/ja active Pending
-
2022
- 2022-11-25 AU AU2022275517A patent/AU2022275517A1/en active Pending
-
2023
- 2023-09-27 JP JP2023166253A patent/JP2023179575A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US10052329B2 (en) | 2018-08-21 |
| IL273932A (en) | 2020-05-31 |
| IL273932B1 (en) | 2023-03-01 |
| ES2964529T3 (es) | 2024-04-08 |
| WO2016007538A1 (en) | 2016-01-14 |
| AU2020203896B2 (en) | 2022-08-25 |
| AU2022275517A1 (en) | 2023-01-05 |
| IL249938B (en) | 2020-04-30 |
| SG10201913641XA (en) | 2020-03-30 |
| CN106794336A (zh) | 2017-05-31 |
| SG11201700061PA (en) | 2017-02-27 |
| EP3166680B1 (en) | 2023-11-15 |
| EP3166680A1 (en) | 2017-05-17 |
| BR112017000285A2 (pt) | 2017-10-31 |
| JP2023179575A (ja) | 2023-12-19 |
| IL249938A0 (en) | 2017-03-30 |
| CN114469958A (zh) | 2022-05-13 |
| AU2015287994B2 (en) | 2020-03-12 |
| MX2017000059A (es) | 2017-11-08 |
| AU2020203896A1 (en) | 2020-07-02 |
| IL273932B2 (en) | 2023-07-01 |
| JP2017527610A (ja) | 2017-09-21 |
| EP3166680A4 (en) | 2018-01-17 |
| KR20170063512A (ko) | 2017-06-08 |
| JP2021138723A (ja) | 2021-09-16 |
| CN106794336B (zh) | 2022-01-11 |
| US20160000797A1 (en) | 2016-01-07 |
| AU2015287994A1 (en) | 2017-02-02 |
| EP4342545A2 (en) | 2024-03-27 |
| CA2954526A1 (en) | 2016-01-14 |
| EP3166680C0 (en) | 2023-11-15 |
| CA2954526C (en) | 2023-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2017009836A0 (en) | Aminopyridyloxypyrazole compounds | |
| GB2541349B (en) | Wall-mounted devices | |
| GB201415573D0 (en) | Compounds | |
| GB201411418D0 (en) | Compounds | |
| GB201410430D0 (en) | Compounds | |
| GB201402431D0 (en) | Compounds | |
| PL3166680T3 (pl) | Profilaktyka przedekspozycyjna anty-hsv | |
| GB201417369D0 (en) | Compounds | |
| GB201416186D0 (en) | Compounds | |
| GB201404987D0 (en) | Compounds | |
| GB201417561D0 (en) | Compounds | |
| GB2515853B (en) | Latency mitigation | |
| GB201406591D0 (en) | Compounds | |
| SG11201701891YA (en) | Stoker-type incinerator | |
| PL3123035T3 (pl) | Śruba | |
| GB201406956D0 (en) | Compounds | |
| AP2017009778A0 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| GB201412660D0 (en) | Compounds | |
| GB201417168D0 (en) | Compounds | |
| GB201407695D0 (en) | Compounds | |
| GB201401005D0 (en) | Inhibitor | |
| GB2529617B (en) | Computing devices | |
| GB201413144D0 (en) | Enclosure | |
| GB201409436D0 (en) | Deodorising device | |
| GB201405361D0 (en) | Compounds |